
The approval of pembrolizumab with brachytherapy could aid individuals who were newly diagnosed with progressive cervical cancer.

The approval of pembrolizumab with brachytherapy could aid individuals who were newly diagnosed with progressive cervical cancer.

Implementing these standards can be logistically challenging.

Christina Madison, PharmD, FCCP, AAHIVP, sat down with Ryan Haumschild, PharmD, MS, MBA, to discuss current issues in oncology.

With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity

Two separate study findings reported that a subset of dormant CD4+ cells could spontaneously produce HIV RNA and proteins, impacting a patient’s HIV-specific immune responses.


Continuous glucose monitors can significantly improve the lives of patients with diabetes, offering less finger pokes, improved compliance, and easier use methods.

Tune in to this episode of "Public Health Matters" to gain a deeper understanding of the challenges, opportunities, and critical conversations surrounding women's sexual health during Sexual Health Awareness Month.

The sNDA is based on data that evaluated belzutifan (Welireg; Merck) compared to everolimus (Afinitor; Novartis) for the treatment of advanced renal cell carcinoma.

Microbubble cell separation can make next generation treatments, such as CAR T-cell therapy, more accessible.

Dapo Amosu, MS, PharmD, DPLA, discusses his thoughts on how to advance medication use processes in inpatient and ambulatory settings and the role of the pharmacist in this endeavor.

If taking tenofovir alafenamide fumarate, a close monitoring of blood pressure and lipid levels are essential due to greater risk of hypertension.

The TJC and IHI advocate for medication reconciliation at all transitions of care.

Investigators of the GLAAD and Gilead COMPASS Initiative survey tracked the progress against HIV stigma, the transmission and prevention of HIV, and the attitudes and knowledge of those living with HIV in the United States.

Cases highlight an acute subdural hematoma and chronic obstructive pulmonary disease.

Despite this decision, the trend of various states attempting to regulate pharmacy benefit managers is expected to continue

In many countries, trastuzumab deruxtecan is the only HER2-targeted therapy approved for patients with this HER2–mutant metastatic non-small cell lung cancer.

Moving cannabis to Schedule 3 will make it easier to research, resulting in the development and creation of new cannabinoid-based pharmaceuticals, with notable potential in oncology.

Pharmacists can help to usher in a new era of patient-centered end-of-life care.

A supplemental New Drug Application will be submitted for roflumilast cream 0.05% for the treatment of mild to moderate atopic dermatitis in children 2 to 5 years of age.

An average patient with heart failure can take up to 6 medications for guideline-directed medical therapy; however, they may have other comorbidities that require pharmacologic management.

The analysis results showed no statistically significant impact on either outcome, but results from prior prospective studies suggest that intravenous immunoglobulin may lengthen hospital stay for patients with severe COVID-19.

Pharmacists play a vital role in providing education and administering influenza, COVID-19, and RSV Vaccines


Shared decision-making can be better incorporated into cardiovascular care guidelines by including decision aids, such as informational flyers or online tools to help patients.

Moderna has advanced 6 programs into late-stage development, including for respiratory conditions, latent and other viruses, oncology, and rare diseases.

Insulin glargine-yfgn is more affordable than the reference product and patients do not require prescriber authorization switch.

Infections were associated with a 1.49-fold increase in the rate of dementia in both the short- and long-term rates, however, the increases were greater in the short term.

Supplemental biologics license application is based on positive results from the phase 3 XTEND-Kids study, demonstrating highly effective bleed protection with once weekly dosing of Altuviiio for children with severe hemophilia A.

In addition to identifying strategies to reduce the adverse effects of sleep and circadian disruption, the study authors identify the impact of obesity on sleep.